Cognito’s Spectris AD slows Alzheimer’s disease progression in trial
Cognito has reported outcomes from a post hoc analysis of its OVERTURE trial, indicating that the Spectris AD can slow the progression of Alzheimer’s. The post Cognito’s Spectris AD slows Alzheimer’s disease progression in trial appeared first on Medical Device Network.
Cognito has reported outcomes from a post hoc analysis of its OVERTURE trial, indicating that the Spectris AD can slow the progression of Alzheimer’s.
The post Cognito’s Spectris AD slows Alzheimer’s disease progression in trial appeared first on Medical Device Network.
